Literature DB >> 19010369

The effect of 23-valent pneumococcal polysaccharide vaccine on immunological priming induced by 7-valent conjugate vaccine in asplenic subjects with beta-thalassemia.

George V Orthopoulos1, Maria C Theodoridou, Vasilis A Ladis, Dimitris K Tsousis, Vana I Spoulou.   

Abstract

The effect of the 23-valent pneumococcal polysaccharide vaccine (PPV) on the 7-valent conjugate (PCV) vaccine-induced priming was evaluated in 35 splenectomised beta-thalassemics [median (range) age: 30 (12-41) years] vaccinated with either PCV/PPV or two PCVs 1 month apart, followed by a PPV booster 12 months later. 28/35 had already received 1-3 PPVs in the past. Different schedules induced similar anamnestic responses; however priming for 3/5 serotypes induced by one or two PCVs, was inferior in subjects who had received > or =2 PPVs in the past when compared with 23 aged-matched PPV-naïve beta-thalassemics. One PPV following PCV does not affect PCV priming; multiple PPVs induce hyporesponsiveness for some serotypes in splenectomised subjects with beta-thalassemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19010369     DOI: 10.1016/j.vaccine.2008.10.070

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Physical and chemical characterization and immunologic properties of Salmonella enterica serovar typhi capsular polysaccharide-diphtheria toxoid conjugates.

Authors:  Changfa Cui; Rodney Carbis; So Jung An; Hyun Jang; Cecil Czerkinsky; Shousun C Szu; John D Clemens
Journal:  Clin Vaccine Immunol       Date:  2009-11-04

2.  Pneumococcal and influenza immunization in asplenic persons: a retrospective population-based cohort study 1990-2002.

Authors:  Joanne M Langley; Linda Dodds; Deshayne Fell; G Ross Langley
Journal:  BMC Infect Dis       Date:  2010-07-22       Impact factor: 3.090

Review 3.  Pneumococcal Vaccination in High-Risk Individuals: Are We Doing It Right?

Authors:  Ioanna Papadatou; Vana Spoulou
Journal:  Clin Vaccine Immunol       Date:  2016-05-06

Review 4.  Prevention of Community-Acquired Pneumonia with Available Pneumococcal Vaccines.

Authors:  Nicola Principi; Susanna Esposito
Journal:  Int J Mol Sci       Date:  2016-12-25       Impact factor: 5.923

5.  Conjugate and 23-valent pneumococcal polysaccharide booster vaccination in asplenic patients with thalassemia major: A randomized clinical trial study.

Authors:  Mohammad Sadegh Rezai; Javad Ghaffari; Mohammadreza Mahdavi; Amir Bahari; Shahram Ala
Journal:  Caspian J Intern Med       Date:  2017

Review 6.  Effectiveness and practical uses of 23-valent pneumococcal polysaccharide vaccine in healthy and special populations.

Authors:  Yang Wang; Jingxin Li; Yuxiao Wang; Wei Gu; Fengcai Zhu
Journal:  Hum Vaccin Immunother       Date:  2017-12-21       Impact factor: 3.452

7. 

Authors:  Hans-Jürgen Laws; Ulrich Baumann; Christian Bogdan; Gerd Burchard; Maximilian Christopeit; Jane Hecht; Ulrich Heininger; Inken Hilgendorf; Winfried Kern; Kerstin Kling; Guido Kobbe; Wiebe Külper; Thomas Lehrnbecher; Roland Meisel; Arne Simon; Andrew Ullmann; Maike de Wit; Fred Zepp
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2020-05       Impact factor: 1.513

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.